High expression of MYEOV reflects poor prognosis in non-small cell lung cancer
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung CancerPLOS ONE, 2013
- Aberrations of NEGR1 on 1p31 and MYEOV on 11q13 in neuroblastomaCancer Science, 2011
- MYEOV is a prognostic factor in multiple myelomaExperimental Hematology, 2010
- Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomasThe Journal of Pathology, 2008
- Amplification of 11q13 in ovarian carcinomaGenes, Chromosomes and Cancer, 2008
- Oncomine 3.0: Genes, Pathways, and Networks in a Collection of 18,000 Cancer Gene Expression ProfilesNeoplasia, 2007
- Metastasis: a question of life or deathNature Reviews Cancer, 2006
- ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasionBiochemical and Biophysical Research Communications, 2006
- MYEOV: A candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancerInternational Journal of Cancer, 2002
- MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomasJournal of Human Genetics, 2002